Evidence map›Paper›PMID 38807183›Full record

ArticleBMC psychology2024

MEM&SO protocol: understanding the determinants of social learning in neurodegenerative diseases.

Pauline Saliou, Julien Chavant, Serge Belliard, Catherine Merck, Vincent de La Sayette, David Wallon, Olivier Martinaud, Francis Eustache, Mickaël Laisney

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMC psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05800028 (Memory and Social Interactions), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05800028 recruitingnot on this map

Memory and Social Interactions: Study in Alzheimer's Disease and Semantic Progressive Aphasia

TypeobservationalSponsorUniversity Hospital, CaenRan2023 to 2026Enrolled192ConditionsAlzheimer Disease, Semantic DementiaArmsLearning new information
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pauline SaliouInserm, U1077, EPHE, UNICAEN, Normandie Université, PSL Université Paris, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine (NIMH), Caen, 14000, France.ORCID https://orcid.org/0009-0001-1408-5581
Julien ChavantInserm, U1077, EPHE, UNICAEN, Normandie Université, PSL Université Paris, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine (NIMH), Caen, 14000, France.ORCID https://orcid.org/0000-0002-0343-925X
Serge BelliardDépartement de Neurologie, CHU Pontchaillou, Rennes, France.
Catherine MerckDépartement de Neurologie, CHU Pontchaillou, Rennes, France.
Vincent de La SayetteInserm, U1077, EPHE, UNICAEN, Normandie Université, PSL Université Paris, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine (NIMH), Caen, 14000, France.
David WallonUniv Rouen Normandie, Normandie Univ, Inserm U1245 and CHU Rouen, Department of Neurology and CNRMAJ, Rouen, F- 76000, France.
Olivier MartinaudInserm, U1077, EPHE, UNICAEN, Normandie Université, PSL Université Paris, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine (NIMH), Caen, 14000, France.
Francis EustacheInserm, U1077, EPHE, UNICAEN, Normandie Université, PSL Université Paris, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine (NIMH), Caen, 14000, France.
Mickaël LaisneyInserm, U1077, EPHE, UNICAEN, Normandie Université, PSL Université Paris, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine (NIMH), Caen, 14000, France. mickael.laisney@ephe.sorbonne.fr.ORCID https://orcid.org/0000-0003-3571-9333

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople with neurodegenerative diseases may have difficulty learning new information, owing to their cognitive impairments. Teaching them techniques for learning in social contexts could alleviate this difficulty. The present study will examine the performances of patients with Alzheimer's disease and patients with the semantic variant of primary progressive aphasia on a memory test administered in three social contexts. The protocol will make it possible to identify determinants of social interactions, social abilities, cognition, and personality that can explain the potentially beneficial effect of social context on learning in these patients.

methodsThirty dyads (patient with primary memory impairment who meets criteria for Alzheimer's disease paired with caregiver), 16 dyads (patient meeting criteria for semantic variant of primary progressive aphasia paired with caregiver), and 46 dyads (healthy controls with no cognitive complaints) will be recruited. A nonverbal memory test (social memory task) will be administered to each dyad in three different social contexts (presence-only, observation, collaboration). Patients and healthy controls will also undergo a neuropsychological assessment to measure social (interactions and abilities), cognitive and personality aspects. Patients will be compared with controls on differential social scores calculated between the presence-only and collaboration contexts, and between the presence-only and observation contexts. A multiple comparative case study will be conducted to identify social, cognitive and personality variables that potentially explain the differential scores in the collaboration and observation contexts. DISCUSSION: For the first time, memory will be assessed in patients with Alzheimer's disease and patients with the semantic variant of primary progressive aphasia in three different contexts (presence-only, observation, collaboration). The multiple comparative case study will make it possible to identify the determinants of memory performance in the social context, in order to create the most beneficial learning context for individual patients, according to their profile.

trial registrationThis study was approved by the Ile de France XI institutional review board (2022-A00198-35), and registered on ClinicalTrials.gov (no. NCT05800028), on April 27, 2023.

Indexed as

Alzheimer DiseaseAphasia, Primary ProgressiveNeuropsychological TestsSocial InteractionSocial LearningAgedCognitionFemaleHumansMaleMiddle AgedNeurodegenerative DiseasesAlzheimer diseaseAphasia, primary progressivePersonalitySocial interaction.Social learning

Identifiers

PMID38807183
PMCPMC11134701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.